Status:
COMPLETED
Assessment of Renal Function in Cirrhotic Patients
Lead Sponsor:
Baylor Research Institute
Conditions:
Liver Failure
Renal Failure
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to help determine whether cystatin C is a more sensitive laboratory measurement for renal function in cirrhotic patients.
Detailed Description
Serum cystatin C, creatinine clearance based calculations, and 125I-Iothalamate clearance (Glofil) will be obtained in 220 patients with cirrhosis. Utilizing this information, the correlation between ...
Eligibility Criteria
Inclusion
- over 18 undergoing evaluation for a liver transplant
Exclusion
- known allergy or sensitivity to 125I-Iothalamate
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 13 2025
Estimated Enrollment :
213 Patients enrolled
Trial Details
Trial ID
NCT01895114
Start Date
December 1 2010
End Date
January 13 2025
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor All Saint's Medical Center in Fort Worth
Fort Worth, Texas, United States, 76104